Par Pharmaceutical (PRX) Tops Q1 EPS by 8c
Tweet Send to a FriendGet Alerts PRX Hot Sheet
Price: $49.98 --0%
EPS Growth %: +92.9%
Financial Fact:
Net product sales: 264.12M
Today's EPS Names:
SHLO, TAOM, SFL, More
EPS Growth %: +92.9%
Financial Fact:
Net product sales: 264.12M
Today's EPS Names:
SHLO, TAOM, SFL, More
Trade PRX Now!
Par Pharmaceutical (NYSE: PRX) reported Q1 EPS of $0.80, $0.08 better than the analyst estimate of $0.72. Revenue for the quarter came in at $271.5 million versus the consensus estimate of $230.84 million.
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Par Pharmaceutical (PRX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Hormel Foods Corp. (HRL) Misses Q1 EPS by 3c; Maintains Outlook
- Signet Jewelers (SIG) Tops Q1 EPS Views; Comsp Up 6.4%; Guides Q2 EPS
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
